首页> 外文OA文献 >Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

【2h】

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

机译：AM1710的药理表征，来自大麻型机构类的推定大麻素CB2激动剂：抗梗阻无中枢神经系统的副作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elizabeth J. Rahn; Ganesh A. Thakur; Jodi Anne T. Wood; Alexander M. Zvonok; Alexandros Makriyannis; Andrea G. Hohmann;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects. [J] . Rahn EJ, Thakur GA, Wood JA, Pharmacology, Biochemistry and Behavior . 2011,第4期

机译：AM1710（一种来自大麻内酯类的推定大麻素CB2激动剂）的药理特性：无中枢神经系统副作用的镇痛作用。
2. Adenosine A(1) receptor agonist induces visceral antinociception via 5-HT1A, 5-HT2A, dopamine D-1 or cannabinoid CB1 receptors, and the opioid system in the central nervous system [J] . Physiology & behavior . 2020,第期

机译：腺苷A（1）受体激动剂通过5-HT1A，5-HT2A，多巴胺D-1或大麻素CB1受体诱导内脏抗妇生，以及中枢神经系统的阿片类药物
3. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination [J] . Tomas-Roig Jordi, Wirths Oliver, Salinas-Riester Gabriela, CNS neuroscience & therapeutics . 2016,第5期

机译：大麻素CB1 / CB2激动剂WIN55212.2在铜氮酮诱导的中枢神经系统脱髓鞘过程中促进少突胶质细胞的分化和神经保护作用。
4. Non-pharmacological correction methods of central nervous system disturbances [C] . Dubrovin V., Zakharova M., Rashavchenko A., 2015 Information Technologies in Innovation Business Conference . 2015

机译：中枢神经系统疾病的非药理校正方法
5. Modulation of the cannabinoid CB1 and CB2 receptor activation in central nervous system disorders. [D] . Zhang, Ming. 2008

机译：中枢神经系统疾病中大麻素CB1和CB2受体激活的调节。
6. Pharmacological characterization of AM1710 a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects [O] . Elizabeth J. Rahn, Ganesh A. Thakur, JodiAnne T. Wood, -1

机译：AM1710的药理表征来自大麻型机构类的推定大麻素CB2激动剂：抗梗阻无中枢神经系统的副作用
7. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? [O] . Yao, B B, Mukherjee, S, Fan, Y, 2009

机译：AM1241的体外药理学表征：大麻素CB2受体的蛋白激动剂？
8. The Chemistry and Pharmacology of Certain Compounds Affecting the Central Nervous System of Animals and Man. A Pharmacological Comparison of Ea 1476 (Tetrahydrocannabinol) Isomers. [R] . Hardman, H. F., Seevers, M. H. 1956

机译：某些化合物的化学和药理学影响动物和人的中枢神经系统。 Ea 1476（四氢大麻酚）异构体的药理学比较。

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

著录项

引文网络

相似文献

相关主题

期刊订阅